Hybrid immunity shown to offer sub-optimal protection against SARS-CoV-2 Omicron variant

By | January 10, 2022
In a new study, researchers evaluated the neutralizing power of the vaccine against SARS-CoV-2 and vaccine plus infection-induced antibodies against the Omicron variant in a live virus neutralization assay.